ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : protozoan
Clear All
Filter by Field of Research
Medical Parasitology (4)
Humoural immunology and immunochemistry (3)
Dental materials and equipment (2)
Infectious Diseases (2)
Innate Immunity (2)
Biologically Active Molecules (1)
Immunology not elsewhere classified (1)
Medical Biochemistry: Carbohydrates (1)
Medical and Health Sciences (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (19)
Filter by Status
Closed (19)
Filter by Scheme
NHMRC Project Grants (14)
Early Career Fellowships (2)
NHMRC Research Fellowships (1)
Project Grants (1)
Research Fellowships (1)
Filter by Country
Search did not return any results.
Filter by Australian State/Territory
Search did not return any results.
  • Researchers (0)
  • Funded Activities (19)
  • Organisations (0)
  • Funded Activity

    Fetal Immune Response To Vertical Transmission Of Toxoplasma Gondii

    Funder
    National Health and Medical Research Council
    Funding Amount
    $320,891.00
    Summary
    Toxoplasma gondii is a parasite that is a leading cause of human abortion and congenital infections of newborns. In addition, recent research implicates Toxoplasma in diagnoses of schizophrenia and other neuromental conditions. Study of Toxoplasma, it's transmission and effects of infection and development of tools such as vaccines and diagnostic technologies will lead to an improvement in health of mothers, newborns and the wider population.
    More information
    Funded Activity

    Regulation Of Glycosylation Pathways In Parasitic Protozoa

    Funder
    National Health and Medical Research Council
    Funding Amount
    $969,869.00
    More information
    Funded Activity

    Targeting Toxoplasma Gondii Latent Stages Responsible For Chronic Disease

    Funder
    National Health and Medical Research Council
    Funding Amount
    $697,107.00
    Summary
    Many microbial pathogens become resistant to host immune response and drugs by entering a slow-growing, dormant state. These stages are commonly responsible for long term, chronic infections. We will investigate the molecular basis of dormancy in Toxoplasma gondii, which infects one in three people. These studies will identify metabolic pathways that are essential for dormancy with the view of developing new therapies for treating long term, recurrent infections.
    More information
    Funded Activity

    Vaccination Against Toxoplasmosis

    Funder
    National Health and Medical Research Council
    Funding Amount
    $162,877.00
    More information
    Funded Activity

    Protective 'coat' Proteins Of An Intestinal Parasite

    Funder
    National Health and Medical Research Council
    Funding Amount
    $73,355.00
    More information
    Funded Activity

    Polysaccharide Biosynthesis As A New Drug Target In Leishmania Parasites

    Funder
    National Health and Medical Research Council
    Funding Amount
    $422,517.00
    Summary
    Leishmania are protozoan parasites that cause a number of important diseases in humans, afflicting more than 12 million people worldwide. There are currently few drugs that target infectious disease causing stages of these parasites. We have recently shown that Leishmania parasites accumulate a highly unusual sugar polymer when they infect mammalian cells, which appears to be important for infectivity. In this proposal , we will investigate how this sugar polymer is made, identify enzymes involv .... Leishmania are protozoan parasites that cause a number of important diseases in humans, afflicting more than 12 million people worldwide. There are currently few drugs that target infectious disease causing stages of these parasites. We have recently shown that Leishmania parasites accumulate a highly unusual sugar polymer when they infect mammalian cells, which appears to be important for infectivity. In this proposal , we will investigate how this sugar polymer is made, identify enzymes involved in its synthesis and develop new chemical tools for generating highly specific inhibitors of Leishmania sugar biosynthesis. This project will provide new insights into processes that are essential for the survival and infectivity of an improtant group of human pathogens, and lead to the development of new classes of enzyme inhibitors with anti-parasite activity.
    Read more Read less
    More information
    Funded Activity

    Small Molecule Therapeutics: From Infectious And Parasitic Diseases To Cancers

    Funder
    National Health and Medical Research Council
    Funding Amount
    $763,845.00
    Summary
    I will lead a team of medicinal chemists to discover better treatments of diseases focused in two major domains. On one hand, I will discover new drugs to treat certain parasitic diseases such as Sleeping Sickness, Chagas disease and malaria, all caused by protozoal parasites. On the other hand, I will discover new drugs to treat certain cancers, in particular acute myeloid leukemia and Burkitt’s lymphoma, caused by dysfunction of certain types of enzymes called histone acetyltransferases.
    More information
    Funded Activity

    Identification Of Novel Strategies To Mediate Immunity Against Intracellular Pathogens

    Funder
    National Health and Medical Research Council
    Funding Amount
    $325,084.00
    Summary
    The immune system consists of two arms - innate and adaptive. Current vaccine strategies rely mainly on adaptive features of the immune system to mediate immunity against pathogens. Many pathogens have evolved sophisticated strategies to manipulate the adaptive immune system to render it ineffective. This project will investigate microbial detection by the innate immune system, and aims to discover novel, more effective strategies to mediate immunity against intracellular pathogens.
    More information
    Funded Activity

    Structure And Biosynthesis Of Entamoeba Histolytica Proteophosphoglycans

    Funder
    National Health and Medical Research Council
    Funding Amount
    $85,380.00
    Summary
    The intestinal parasite, Entamoeba histolytica is the cause of amoebic dysentry and liver abscess. It is the second most important parasitic disease after malaria, infecting 50 million people and causing 110 000 deaths annually. We have recently shown that the cell surface of infective stages of this parasite are coated by an unusual class of macromolecules called proteophosphoglycans (PPGs). These molecules appear to be major virulence factors, and the expression of PPGs with particular sugar m .... The intestinal parasite, Entamoeba histolytica is the cause of amoebic dysentry and liver abscess. It is the second most important parasitic disease after malaria, infecting 50 million people and causing 110 000 deaths annually. We have recently shown that the cell surface of infective stages of this parasite are coated by an unusual class of macromolecules called proteophosphoglycans (PPGs). These molecules appear to be major virulence factors, and the expression of PPGs with particular sugar modifications is associated with highly pathogenic strains. This proposal aims to determine the precise structure of the PPGs and to define functionally important domains in these molecules. We will also investigate how these molecules are assembled and processed in the parasite. In particular, we aim to characterize enzymes that generate PPG structures only found in virulent strains of Entamoeba histolytica. Assays will be established for these enzymes which will allow us to screen for inhibitors that may be used as potential anti-amoebic drugs. These studies will provide insights into the surface chemistry of these important human parasites and identify new drug targets.
    Read more Read less
    More information
    Funded Activity

    Functional Studies On Two Essential Rhoptry Proteins Of The Malaria Parasite

    Funder
    National Health and Medical Research Council
    Funding Amount
    $470,894.00
    Summary
    Malaria is one of the most important and deadly infectious diseases in the world, causing 250 million cases and nearly one million deaths each year. Traditionally, drugs and insecticides have been used to treat the disease and control its spread. They have become much less effective and there now exist untreatable cases of malaria. Alternative control measures are urgently needed. An understanding of how proteins essential to parasite survival operate may identify novel targets for therapeutic i .... Malaria is one of the most important and deadly infectious diseases in the world, causing 250 million cases and nearly one million deaths each year. Traditionally, drugs and insecticides have been used to treat the disease and control its spread. They have become much less effective and there now exist untreatable cases of malaria. Alternative control measures are urgently needed. An understanding of how proteins essential to parasite survival operate may identify novel targets for therapeutic intervention against this devastating disease.
    Read more Read less
    More information

    Showing 1-10 of 19 Funded Activites

    • 1
    • 2
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback